Powdered pharmaceutical composition, kit, and methods for the prophylaxis or treatment of asthma, for the prophylaxis or treatment of chronic obstructive pulmonary disease, to reduce or deplete adenosine in a patient's tissue, and for the prophylaxis or treatment of a disorder. or condition associated with high levels or adenosine sensitivity in a patient's tissue

摘要

"PHARMACEUTICAL COMPOSITION POWDER, KIT, AND METHODS FOR PROPHILAXY OR TREATMENT OF ASTHMA, FOR PROPHILAXY OR CHRONIC DISEASE TREATMENT, TO REDUCE OR EXHAURATE ADENOSINE FOR A TISSUE AND A TISSUE TO THE TISSUE OF A PROTEXIA DISTURBANCE OR CONDITION ASSOCIATED WITH HIGH LEVELS OR SENSITIVITY TO ADENOSINE IN A PATIENT FABRIC ". The invention relates to a powder formulation comprising a sulfate covalently bound dehydroepiandrosterone dihydrate, its analog (s) or salt (s) itself, and a pharmaceutically and veterinarily acceptable carrier, and having a size of particle of about 0.1 µm to about 100 µm. The formulation may be used to treat or prevent asthma, chronic obstructive pulmonary disease, lung inflammation, SARS, and other respiratory diseases or conditions. The formulation may be prepared by jet milling, and may be delivered through the respiratory tract or other routes. The formulation is provided in one device and one therapeutic kit.